Systemic Solutions and Policy Implications for End-of-Life Care

Key Insight

The default mode of modern medicine is to fight death and disease at all costs, often fueled by financial incentives that reward aggressive treatments but not the time required for crucial end-of-life discussions. This approach pushes patients through debilitating, low-efficacy treatments, often prolonging suffering and incurring immense costs, without adequate preparation for the inevitable. The underlying issue is an unresolved debate about the true function of medicine beyond simply fighting disease.

Past attempts to control costs or challenge aggressive treatment decisions by insurers have largely failed due to public and legal backlash, as seen in the Nelene Fox case, where an insurer's denial of an ineffective experimental treatment led to an $89 million jury verdict. However, innovative programs like Aetna's 'concurrent care,' which allowed terminally ill patients to receive hospice services without forgoing other treatments, proved highly successful. This program led to a jump in hospice enrollment from 26 percent to 70 percent, a halving of emergency room visits, a two-thirds reduction in hospital and ICU use, and an almost 25 percent decrease in overall costs.

Community-level initiatives demonstrate that systemic change is achievable through proactive communication. In La Crosse, Wisconsin, a systematic campaign starting in 1991 led to 85 percent of residents having written advance directives by 1996, up from 15 percent. This resulted in their elderly residents spending half the national average days in the hospital during their last six months, with no premature cessation of care, and even a year longer life expectancy than the national average. The success of these models, including a landmark 2010 study showing palliative care patients lived 25 percent longer and suffered less, highlights that comprehensive, early discussions about end-of-life preferences are a powerful and cost-effective intervention.